Special Report: Marijuana Outlook: Best Stocks to Buy

There's no doubt about it...

In 2016, investors made an absolute fortune in pot stocks.

But had you told me 10 years ago that the fastest-growing market in the U.S. would be legal marijuana, I would've guessed you were high.

After all, in 2005, prohibition had been in effect for nearly 70 years, and there was no indication that there would be any support by lawmakers for such a thing. But then something very exciting happened...

A few very smart politicians realized they could make a lot of money for their districts through the taxation of marijuana. Sure, conservatives wouldn't like it, but the overriding mentality of lawmakers has always been: “Cash rules everything around me.”

And so it began.

Why States Suddenly Love Pot

In the United States, Colorado is currently the best example of marijuana legalization. The state government there has seen substantial increases in tax collections due in large part to excise taxes on marijuana. 

With Colorado breaching $100 million in monthly marijuana sales, politicians in state legislatures around the country are licking their chops for more money, and many of them will end up going along with legalization just for that.

In terms of taxation and use of resources, we must also consider that legalization means fewer resources will be required to put people in front of courts and to hold people in prison. When you don’t arrest sellers and users of marijuana, it means that government spending can be reduced or resources diverted to something else — hopefully something that involves actual criminals.

Many areas already have severe overcrowding in jails and backed-up cases in court. Legalizing marijuana will only help this situation.

Hemp and Other Uses

When we talk about the economics of legalization, we really need to focus on everything. Marijuana use itself is not the only result of legalizing cannabis.

Hemp is a product derived from the same plant species as marijuana. In the United States, hemp production is essentially illegal under federal law, even though hemp itself contains little THC, which is the chemical in marijuana that gets people high. This just shows the ridiculousness of the laws. This is cronyism and has nothing to do with protecting people from themselves. It limits our economic freedom.

When you consider all of the products that we are being deprived of, it is easy to understand the economic benefits of legal cannabis, particularly with hemp. This is also one of those things where it is very difficult to measure. Looking at GDP statistics isn’t going to help us.

Just take smartphones as a simple example. When someone buys a smartphone, it will get reflected in GDP statistics. But this is mostly meaningless because it is not telling us how much happiness people are deriving from the product.

If smartphones didn’t exist, we don’t know what people would have used that extra money for. But smartphones do exist now, and the majority of people have decided it is worth their money to have one. For this reason, we are generally much better off for having this product available.

The same would go for hemp and all of its uses. Think of all of the choices in clothes, paper products, biofuels, rope, and so many other products that we may be missing out on. We don’t really know all that is possible until it is fully legalized and the marketplace figures it out.

As with any product, when you lift restrictions and allow free people to have more choices, then this improves living standards. And when it comes to economics, free choice and living standards are really what matter the most. It isn’t some GDP statistic that makes you happy.

Medical Marijuana

Even medical marijuana has a major economic impact. Just as with the use of hemp, more choice and freedom means a higher quality of life. This is actually an economic benefit.

Of course, if medical marijuana helps someone live longer or have a higher quality of life by feeling better, how can you get a bigger economic impact than this?

The other major factor we have to consider with medical marijuana is its impact on traditional medicine. What if more people try marijuana for medicinal uses such as treating diseases like cancer? What if people find success in using marijuana as a replacement for expensive drugs?

Some medical providers and pharmaceutical companies may not like this very much. In fact, they might find it in their own interest to argue against medical marijuana.

Now, it is true that some in the medical industry could be hurt by success stories in the use of medical marijuana. But we have to make sure that we use good economics in our analysis.

The overall economic impact is positive if people find marijuana is cheaper and more effective than traditional drugs. It may hurt the bottom line of some major drug companies, but it will help the bottom line of many individuals struggling with health issues.

Again, if people are making a voluntary choice to use a product, it is because they deem themselves better off. They are willing to trade their money for the product.

What Comes Next...

Today, 23 states plus the District of Columbia have some sort of marijuana legalization in place.

Next year, it will be more than half the nation.

Outside of the U.S., Canada is on the cusp of legalizing marijuana throughout the entire country.

Mexico's Supreme Court recently approved the first step in legalization, and we're starting to see more and more progress in South America, where cannabis is completely legal in Uruguay and is decriminalized in Ecuador, Peru, Bolivia, Chile, Argentina, and Brazil.

And this is all happening at light speed!

Just look at this map. Highlighted are all the states and countries where marijuana is legal or decriminalized.

mjmap

Considering what that map shows, it's not surprising that so many folks are looking for a way to profit from this burgeoning industry.

Certainly we've been at it for some time now, doubling our money on a few of these stocks just over the past six months.

Make no mistake; the legal marijuana market is booming. But that doesn't mean all marijuana stocks are going to make you rich.

Moving Onward, Moving Upward

A few years ago, roughly 90% of all legal marijuana stocks were dogs, scams, and fly-by-night operations.

There was a huge run, then a huge crash. What remained was a handful of companies that were actually legitimate.

It's unfortunate that it had to go down this way, but it's really no different than any other new, exciting market.

That being said, a sizable portion of the marijuana space has been cleared of the empty shells and laggards.

What remains is a market that's a bit more credible than it was just two years ago, a market that's being embraced by a growing number of state, regional, and national governments.

Of course, the question is, which are the best marijuana stocks to own in 2017?

The Marijuana Industry's Best Friend

There are three things I want in a legal marijuana stock.

First, exposure to Canada.

Marijuana will soon be legal throughout the entire country of Canada. Those companies that are already operational in the medical marijuana space and are actively generating revenue in Canada are key targets.

Second, exposure to the edibles market.

Last year in Colorado alone, consumers bought 5.8 million marijuana-infused edibles and concentrate products.

Earlier this year, a small specialty edibles company quickly closed a $1.25 million round of financing.

Would you have ever imagined a company making pot brownies would be able to close a $1.25 million round of financing?

The truth is, many doctors prefer their patients ingest medical marijuana instead of smoking it, as there are still adverse effects from smoking. It's not good on the lungs!

As well, newcomers to the legal marijuana industry tend to be non-smokers. Cookies, candy, brownies, and oils offer consumers something that's a bit cleaner, a bit safer, and allows folks to avoid the negative stereotype of a pot smoker.

Edibles are definitely going to be huge.

And finally, there's the pharmaceutical angle.

Creating marijuana-based therapies is going to be big business. I'm talking on the level of Viagra and Tamiflu.

Marijuana has been used for centuries to treat all kinds of illnesses and diseases. But now that prohibition is on its way out, the pharmaceutical industry knows it must dip its beak in the waters of cannabis therapies.

From arthritis and epilepsy to PTSD and anxiety, marijuana continues to provide relief for millions of people. As the erosion of marijuana prohibition continues, more and more folks will have access to these therapies and, of course, demand them.

Consumer behavior, my friend. It's the legal marijuana industry's best friend!

Don't Sit This One Out

Now, there are actually a number of legal marijuana stocks that fall into these categories. And of course, some are riskier than others. So when looking into these companies, be sure to do your due diligence so you know exactly what you're getting into.

While we won't be taking a look at all of our top marijuana stocks today, here are a few we've recently decided to put on the watch list for 2017:

  • GW Pharmaceuticals (NASDAQ: GWPH)
  • Aphria, Inc. (TSX-V: APH)
  • Canopy Growth Corporation (TSX-V: CGC)
  • INSYS Therapeutics (NASDAQ: INSY)
  • Kaya Holdings (OTC: KAYS)

2017 is definitely going to be an exciting year in the legal marijuana space.

The bottom line is that we're about to witness the end of marijuana prohibition in North America. At this point, only a fool would ignore this opportunity to make a boatload of cash.

Don't sit this one out.

________________________________

Before we part, we'd like to extend a sincere thank-you for joining us here at Wealth Daily. We look forward to providing you with valuable investment research and commentary over the course of your subscription. Our core philosophy is that the more you know, the better you'll be able to take advantage of that knowledge and expand your wealth. We'll continue to share our insights on how you can boost your portfolio with flexible and safe investments that will help you break free of the traditional trading advantages, traps, and pitfalls financial institutions use to siphon off your wealth.

Sincerely,

Wealth Daily Research Team


Wealth Daily, Copyright © 2017, Angel Publishing LLC. All rights reserved. 111 Market Place #720 Baltimore, MD 21202. The content of this site may not be redistributed without the express written consent of Angel Publishing. Individual editorials, articles and essays appearing on this site may be republished, but only with full attribution of both the author and Wealth Daily as well as a link to www.wealthdaily.com. Your privacy is important to us -- we will never rent or sell your e-mail or personal information. View our privacy policy here. No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. Wealth Daily does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question.